Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company. Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
View Top Employees from Avenue TherapeuticsWebsite | http://www.avenuetx.com |
Ticker | ATXI |
Revenue | $1 million |
Funding | $33 million |
Employees | 11 (10 on RocketReach) |
Founded | 2015 |
Address | 2 Gansevoort Street 9th Floor, New York, New York 10014, US |
Phone | (781) 652-4500 |
Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Pharmaceutical, Business Services, Health Care |
Competitors | MediQuest Therapeutics, Inc., MediciNova, Inc., Relmada Therapeutics, Inc, Urigen Pharmaceuticals, Inc., Yaupon Therapeutics, Inc |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Avenue Therapeutics employee's phone or email?
The Avenue Therapeutics annual revenue was $1 million in 2024.
10 people are employed at Avenue Therapeutics.
Avenue Therapeutics is based in New York, New York.
The NAICS codes for Avenue Therapeutics are [3254, 32541, 325, 32].
The SIC codes for Avenue Therapeutics are [28, 283].